Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine M Kelly

Showing results (21-30 of 65) with videos related to

Pageof 7
Sort By:
The Oncologist|April 28, 2010
Review of the clinical studies using the 21-gene assayCatherine M Kelly, Ellen Warner, Daphne T Tsoi, et al.
Physical Chemistry Chemical Physics : PCCP|March 3, 2015
Structure and dynamics of the fibronectin-III domains of Aplysia californica cell adhesion moleculesCatherine M Kelly, Julien Muzard, Bernard R Brooks, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 4, 2010
Disseminated tumor embolism from breast cancer leading to multiorgan failureDaphne T Tsoi, Corwyn Rowsell, Caitlin McGregor, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 7, 2015
Women's experiences of hormonal therapy for breast cancer: exploring influences on medication-taking behaviourCaitriona Cahir, Stephan U Dombrowski, Catherine M Kelly, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 4, 2023
Informing interventions to improve uptake of adjuvant endocrine therapy in women with breast cancer: a theoretical-based examination of modifiable influences on non-adherenceCaitriona Cahir, Kathleen Bennett, Stephan U Dombrowski, et al.
Regulatory Toxicology and Pharmacology : RTP|July 28, 2009
A lifetime cancer bioassay of quinacrine administered into the uterine horns of female ratsAida M Cancel, John E Dillberger, Catherine M Kelly, et al.
Cardio-Oncology (London, England)|February 24, 2021
Competing mortality risks: predicted cardiovascular disease risk versus predicted risk of breast cancer mortality in patients receiving adjuvant chemotherapy in a single Irish centerLisa Prior, Hannah Featherstone, David O'Reilly, et al.
Cancer|July 29, 2010
Utility of oncotype DX risk estimates in clinically intermediate risk hormone receptor-positive, HER2-normal, grade II, lymph node-negative breast cancersCatherine M Kelly, Savitri Krishnamurthy, Giampaolo Bianchini, et al.
Biophysical Chemistry|September 22, 2014
Conformational dynamics and aggregation behavior of piezoelectric diphenylalanine peptides in an external electric fieldCatherine M Kelly, Thomas Northey, Kate Ryan, et al.
BMJ (Clinical Research Ed.)|February 10, 2010
Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort studyCatherine M Kelly, David N Juurlink, Tara Gomes, et al.
Pageof 7

Showing results (21-30 of 65) with videos related to

Sort By:
Pageof 7
The Oncologist|April 28, 2010
Review of the clinical studies using the 21-gene assayCatherine M Kelly, Ellen Warner, Daphne T Tsoi, et al.
Physical Chemistry Chemical Physics : PCCP|March 3, 2015
Structure and dynamics of the fibronectin-III domains of Aplysia californica cell adhesion moleculesCatherine M Kelly, Julien Muzard, Bernard R Brooks, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 4, 2010
Disseminated tumor embolism from breast cancer leading to multiorgan failureDaphne T Tsoi, Corwyn Rowsell, Caitlin McGregor, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 7, 2015
Women's experiences of hormonal therapy for breast cancer: exploring influences on medication-taking behaviourCaitriona Cahir, Stephan U Dombrowski, Catherine M Kelly, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 4, 2023
Informing interventions to improve uptake of adjuvant endocrine therapy in women with breast cancer: a theoretical-based examination of modifiable influences on non-adherenceCaitriona Cahir, Kathleen Bennett, Stephan U Dombrowski, et al.
Regulatory Toxicology and Pharmacology : RTP|July 28, 2009
A lifetime cancer bioassay of quinacrine administered into the uterine horns of female ratsAida M Cancel, John E Dillberger, Catherine M Kelly, et al.
Cardio-Oncology (London, England)|February 24, 2021
Competing mortality risks: predicted cardiovascular disease risk versus predicted risk of breast cancer mortality in patients receiving adjuvant chemotherapy in a single Irish centerLisa Prior, Hannah Featherstone, David O'Reilly, et al.
Cancer|July 29, 2010
Utility of oncotype DX risk estimates in clinically intermediate risk hormone receptor-positive, HER2-normal, grade II, lymph node-negative breast cancersCatherine M Kelly, Savitri Krishnamurthy, Giampaolo Bianchini, et al.
Biophysical Chemistry|September 22, 2014
Conformational dynamics and aggregation behavior of piezoelectric diphenylalanine peptides in an external electric fieldCatherine M Kelly, Thomas Northey, Kate Ryan, et al.
BMJ (Clinical Research Ed.)|February 10, 2010
Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort studyCatherine M Kelly, David N Juurlink, Tara Gomes, et al.
Pageof 7